✦ LIBER ✦

Skin test evaluation of genetically engineered hypoallergenic derivatives of the major birch pollen allergen, Bet v 1: Results obtained with a mix of two recombinant Bet v 1 fragments and recombinant Bet v 1 trimer in a Swedish population before the birch pollen season☆☆☆★

✍ Scribed by van Hage-Hamsten, Marianne; Kronqvist, Marianne; Zetterström, Olle; Johansson, Eva; Niederberger, Verena; Vrtala, Susanne; Grönlund, Hans; Grönneberg, Reidar; Valenta, Rudolf

Book ID: 119497095
Publisher: Elsevier Science
Year: 1999
Tongue: English
Weight: 84 KB
Volume: 104
Category: Article
ISSN: 1097-6825
DOI: 10.1016/s0091-6749(99)70077-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Vaccines for birch pollen allergy based

Vaccines for birch pollen allergy based on genetically engineered hypoallergenic derivatives of the major birch pollen allergen, Bet v 1

✍ V. Mahler; S. Vrtala; O. Kuss; T. L. Diepgen; R. Suck; O. Cromwell; H. Fiebig; A 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 656 KB

Comparison of inflammatory responses to

Comparison of inflammatory responses to genetically engineered hypoallergenic derivatives of the major birch pollen allergen Bet v 1 and to recombinant Bet v 1 wild type in skin chamber fluids collected from birch pollen–allergic patients

✍ Nopp, Anna; Halldén, Gunilla; Lundahl, Joachim; Johansson, Eva; Vrtala, Susanne; 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 77 KB

Suppression of antigen-specific T- and B

Suppression of antigen-specific T- and B-cell responses by intranasal or oral administration of recombinant Bet v 1, the major birch pollen allergen, in a murine model of type I allergy

✍ Wiedermann, Ursula; Jahn-Schmid, Beatrice; Bohle, Barbara; Repa, Andreas; Renz, 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 226 KB